Author Archives: Andrew T. Chan, Uri Ladabaum

In 2007, the United States Preventive Services Task Force (USPSTF) recommended against the routine use of aspirin for the prevention of colorectal cancer (CRC). However, in September 2015, the USPSTF reversed this stand in its updated draft guidelines and provided low-dose aspirin (pragmatically, 81 mg/d in the United States) with a grade “B” recommendation for chronic disease prophylaxis, including CRC prevention, among US adults between ages 50 and 59 with a >10% 10-year risk of cardiovascular (CVD) events. Continue reading →